Katelyn O'Brien, PharmD, BCPS, CDCES, BC-ADM
@KOBPharmD
Clinical Pharmacy Specialist #ambcarerx All things #diabetes and #CGM Opinions are my own. she/her/hers
ID:1174093128632066049
17-09-2019 22:49:57
1,9K Tweets
1,5K Followers
1,5K Following
Looking forward to presenting at this conference! #pharmacists #diabetes #obesity #incretins #healthdisparities
Post the last photo of your pet, no cheating
#dogtwitter moments later he walked to my room and jumped into bed, at 8:30pm. Enough said!
🚨 The U.S. FDA has designated the EversenseCGM as an integrated #CGM and will allow the device to be used with insulin pumps and automated insulin delivery systems.
Read more ⤵️ Ascensia Diabetes Care
healio.com/news/endocrino…
Lucky to be able to work with and learn from such dedicated and caring diabetes clinicians like Devin! Boston Medical Center
Cant wait for the scientific sessions, great learning &networking! Register today, hope to see you there.
I’ll be speaking on a panel Saturday: “The Role of the Interdisciplinary Team in Technology Onboarding in Primary Care” #diabetescare #diabetestechnology #diabeteseducation
I’m so excited to join Susan G. Weiner, RD as she hosts the next episode of American Diabetes Association - DiabetesPro “Ask the Expert” event on medications. Join on 4/9 ! #diabetes #pharmacist #TwitteRx
Encourage people living with diabetes to join us for an Ask the Experts event on Tuesday, April 9 at 2:00 p.m. ET. We'll be discussing medications used to manage diabetes and the types that can work best. Register at bit.ly/49bxEcK. #KnowDiabetesbyHeart
Susan G. Weiner, RD
Great news! Hope to see improvements in production with expanded access and coverage. #MedTwitter
“Medicare couldn’t cover #Wegovy for #weightloss . But now that it’s also a heart drug, the door is open”
STAT Rachel Cohrs Zhang
statnews.com/2024/03/14/med…
#cardiotwitter #obesity
Looking forward to the conference MA Coordinating Body ADCES register today: adces.org/events/unliste…
Thanks to CeQur for sponsoring Fridays dinner program!
#diabetes #diabetes education #cardiorenalmetabolic #diabetes complications #diabetes conference
It was a real pleasure working with Wendy St. Peter and Jay SHUBROOK on this review discussing opportunities for pharmacists to improve outcomes for people with T2D and CKD JCM MDPI
doi.org/10.3390/jcm130…
Announcement from Novo Nordisk re the FLOW trial:
Semaglutide reduced the risk of 50% decline in eGFR, kidney failure, or death due to kidney or cardiovascular disease by 24%
Results to be presented this year by trial PI Vlado Perkovic & colleagues
novonordisk.com/content/nncorp…